TE_105
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIR1_Amn |
|---|---|
| TE superfamily | L2-end |
| TE class | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 2.13 |
| Counts of samples | TCGA_tumor:565; TCGA_normal:19; GTEx:279 |
| TSS | chr1(-):10920371 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_105.11 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917199,10918513,10918733,10920209,10920372 |
| teRNA_105.12 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913753,10913885,10916996,10917250,10920209,10920372 |
| teRNA_105.13 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917250,10920209,10920372 |
| teRNA_105.14 | - | Intergenic | Non-coding | Non-coding | chr1(-):10911980,10912000,10913829,10913885,10916996,10917250,10920209,10920372 |
| teRNA_105.15 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913144,10913164,10913829,10913885,10916996,10917250,10920209,10920372 |
| teRNA_105.16 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917250,10918513,10918777,10920209,10920372 |
| teRNA_105.17 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917199,10920209,10920372 |
| teRNA_105.18 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917250,10918513,10918722,10920209,10920372 |
| teRNA_105.19 | - | Intergenic | Non-coding | Non-coding | chr1(-):10913189,10913209,10913829,10913885,10916996,10917250,10918513,10918642,10920209,10920372 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
